Jan 11, 2022 / 02:00PM GMT
Eric Joseph - PhD,
Welcome again to the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst with the firm. And our next presenting company is Kymera Therapeutics. It's my pleasure to welcome the company's CEO, Nello Mainolfi, to talk to us a little bit about the company. There is a Q&A session after the presentation. Feel free to submit questions by clicking the icon over there, and I'll work them in where appropriate. So with that, Nello, thanks for showing some of your time with us this morning.
Nello Mainolfi - Kymera Therapeutics, Inc. - Co-Founder, President, CEO & Director
Thanks, Eric. Thanks for the invitation to participate in the conference. I'm excited to share with everybody our story today. So first of all, maybe just to remind everybody, Kymera has been evolving quite rapidly in the past 2, 3 years. I would say, thanks to an amazing team of dedicated, I call it, R&D entrepreneurs, but also thanks to supporting both partners and investors. So today, I do want to talk about our pipeline progression and the
Kymera Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers